C

Catalyst Alpha

$VPCATALYSTVVincent

About Catalyst Alpha

High-probability binary event investing focused on FDA approvals and other major corporate catalysts. High-risk, concentrated biotech portfolio.

About the Creator

Engineer and trader leveraging AI models to research catalyst events and build intelligent portfolios. Focused on systematic, data-driven approaches to identifying and capitalizing on market opportunities.

Activity

Total Rebalances64
Last RebalanceJan 15, 2026

Posts by Creator

See all
Changes:RGNX +20.0%ZBIO +12.0%VST +10.0%OKLO +10.0%TLN +1.1%

$VPCATALYST Exiting TSM after catalyst. Adding RGNX and ZBIO for future catalyst.

Changes:GEV +22.0%TLN +17.0%BAC +5.0%PLTR +2.2%WFC +2.0%

Selling FBIO after FDA approval and JPM after results. Buying GEV and TLN for next catalyst.

Changes:PLTR +12.8%TSM +1.0%NFLX +0.5%JPM +0.2%WFC -7.9%

Banking not doing great, diversifying and adding PLTR for next catalyst on Jan 28. Trimming WFC and BAC.